Header cover image

Polish (WIG) Biotech Industry Analysis

UpdatedJun 28, 2022
DataAggregated Company Financials
Companies14
  • 7D-1.3%
  • 3M-14.2%
  • 1Y-50.7%
  • YTD-35.7%

The Biotech is pretty flat in the last 7 days, but BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek has stood out, gaining 5.4%. As for the longer term, the industry has declined 51% in the last year. Looking forward, earnings are forecast to grow by 71% annually.

Industry Valuation and Performance

Has the Polish Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPE
Tue, 28 Jun 2022zł2.3bzł472.9mzł66,686.0024.9x
Thu, 26 May 2022zł2.5bzł426.5mzł14.0m35x
Sat, 23 Apr 2022zł2.8bzł369.1m-zł37,778,677.0036.1x
Mon, 21 Mar 2022zł2.8bzł348.8m-zł40,884,677.0033.1x
Wed, 16 Feb 2022zł3.1bzł348.5m-zł40,520,361.0051.5x
Fri, 14 Jan 2022zł3.7bzł369.9m-zł24,922,742.0049.5x
Sun, 12 Dec 2021zł3.7bzł369.9m-zł24,922,742.0049.8x
Tue, 09 Nov 2021zł3.6bzł368.8mzł763.7k32.8x
Thu, 07 Oct 2021zł3.5bzł364.5m-zł1,455,285.0033.3x
Sat, 04 Sep 2021zł3.7bzł362.9m-zł8,912,285.0038.8x
Mon, 02 Aug 2021zł3.6bzł362.9m-zł8,912,285.0037.4x
Thu, 06 May 2021zł3.8bzł373.1m-zł6,705,220.00122x
Sun, 07 Feb 2021zł1.6bzł382.5mzł56.4m110.3x
Sat, 31 Oct 2020zł2.1bzł307.0m-zł7,012,804.0059.4x
Tue, 04 Aug 2020zł2.5bzł289.2m-zł30,736,114.0037.7x
Fri, 08 May 2020zł851.1mzł304.1m-zł149,014,103.0047.7x
Mon, 10 Feb 2020zł581.0mzł295.6m-zł128,943,953.0036.7x
Sun, 03 Nov 2019zł592.9mzł300.9m-zł129,547,264.0028.2x
Wed, 07 Aug 2019zł1.9bzł302.3m-zł201,837,301.0031.6x
Median PE Ratio

32.3x


Total Market Cap: zł1.7bTotal Earnings: -zł201,837,301.00Total Revenue: zł302.3mTotal Market Cap vs Earnings and Revenue0%0%0%
Polish Biotech Industry Median PE3Y Average 50.2x202020212022
Current Industry PE
  • Investors are optimistic on the industry, and appear confident in long-term growth rates.
  • The industry is trading at a PE ratio of 35kx which is higher than its 3-year average PE of 72.7x.
  • The industry's 3-year average PS ratio 6.2x is higher than the industry's current PS ratio of 4.9x.
Past Earnings Growth
  • Total earnings for the Biotechnology industry have gone up over the last three years, and the industry is now profitable. Revenues have grown 16% per year.
  • This means that more sales are being generated by the industry overall, and subsequently profits are increasing too.

Industry Comparison

How does Polish Biotech compare with similar industries?

PL Market1.63%
Healthcare2.76%
Biotech-1.26%
Biotech-1.26%
Industry PEThere is insufficient data on the sub-industries of this industry.
Forecasted GrowthThere is insufficient data on the sub-industries of this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
BML BIOMED-LUBLIN Wytwórnia Surowic i Szczepionekzł3.152.6%
+zł5.2m
-66.8%PS44x
GMT Genomteczł6.086.5%
+zł3.0m
-53.1%PS237.6x
URT Urtestezł89.802.3%
+zł2.3m
n/an/a
SCS Stem Cells Spinzł0.379.4%
+zł1.3m
-69.3%PS50.7x
BER Bioerg Spólka Akcyjnazł0.160.3%
+zł50.8k
-46.3%PS3.2x
Simply Wall St
Simply Wall Street Pty Ltd
17-21 Bellevue Street, Surry Hills, Sydney
Download on the App StoreGet it on Google Play
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

MAB

zł21.84

Mabion

7D

-0.09%

1Y

-70.1%

GX1

zł15.22

genXone

7D

-0.5%

1Y

-43.3%

RDG

zł2.41

Read-Gene

7D

-0.8%

1Y

-18.9%

GMT

zł6.08

Genomtec

7D

6.5%

1Y

-53.1%

BIO

zł3.93

BIOTON

7D

-0.1%

1Y

-24.7%